Dr. Seema Ali Bhat, MD

Dr. Bhat practices at OSU Internal Medicine in Columbus, Ohio.

Dr. Bhat's NPI, 1558524926, was assigned on July 7, 2008. Dr. Bhat holds Ohio license 35134788.

Dr. Bhat's primary practice is OSU Internal Medicine, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-2229.

Dr. Bhat's primary practice is OSU Internal Medicine in Columbus, Ohio. Dr. Bhat is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Bhat to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhat practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bhat's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Bhat's licenses on file in 2 states: Ohio and New York.

CMS data shows 792 Medicare services from Dr. Bhat across 7 procedure codes in 2024, for 223 Medicare patients. Medicare paid $43,609 for them.

CMS counts 223 Medicare patients who saw Dr. Bhat in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 66% have high cholesterol. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhat's median patient age at 71, with 42% women.

In 2024, Dr. Bhat wrote 466 Medicare Part D claims for 54 patients. 3% of them were for generic drugs. CMS names the drug for 451 of them, across 6 drugs with 11 or more claims each, at $6,269,617 in total drug cost. In 2023, CMS named 349 claims across 4 drugs.

Dr. Bhat accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 50 papers to Dr. Bhat, published from 2013 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Hairy Cell and Adenine. Dr. Bhat has published most often in Leukemia. Dr. Bhat's most frequent co-authors are Kerry Anne Rogers, MD, Jennifer Ann Woyach, MD and John C. Byrd, MD.

Dmand AI links Dr. Bhat to 5 clinical trials, 2 of them phase 1/2 studies. 2 are still active or recruiting. Conditions studied include Lymphoma, Mantle-Cell, Leukemia, Lymphocytic, Chronic, B-Cell and Leukemia, B-Cell.

CMS Open Payments shows 98 general payments to Dr. Bhat from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. AstraZeneca Pharmaceuticals LP paid the most, $29,958. It also lists 9 research payments totaling $1,416 in 2023.